Skip to main content
. 2023 Mar 23;25(Suppl 1):124–135. doi: 10.1007/s11121-023-01496-3

Table 4.

CRCCP clinic characteristics by existence of mailed fecal testing

Implemented mailed fecal testing Did not implement mailed fecal testing p for χ2 testa
n % n %
All clinics (n = 185) 108 58.4 77 41.6
Clinic type 0.30
  CHC/FQHC (n = 147) 88 81.5 59 76.6
  HS/hospital owned (n = 19) 8 7.4 11 14.3
  Other (n = 19) 12 11.1 7 9.1
Urban–rural status 0.12
  Metro (n = 150) 84 77.8 66 85.7
  Urban (n = 25) 16 14.8 9 11.7
  Rural (n = 5) 5 4.6 0 0.0
  Unknown (n = 5) 3 2.8 2 2.6
% patients uninsured 0.01
   < 5% (n = 51) 33 30.6 18 23.4
  5–20% (n = 67) 43 39.8 24 31.2
   > 20% (n = 42) 16 14.8 26 33.8
  Unknown (n = 25) 16 14.8 9 11.7
Number of patients 0.00
   ≤ 700 (n = 65) 35 32.4 30 39.0
   > 700–1700 (n = 59) 28 25.9 31 40.3
   > 1700 (n = 59) 45 41.7 14 18.2
  Missing (n = 2) 0 0.0 2 2.6
Number of providers 0.48
   < 5 (n = 91) 56 51.9 35 45.5
  5–9 (n = 38) 19 17.6 19 24.7
  ≥10 (n = 51) 30 27.8 21 27.3
  Missing (n = 5) 3 2.8 2 2.6
Primary test type 0.05
  Colonoscopy (n = 55) 26 24.1 29 37.7
  FIT/FOBT kits (n = 105) 66 61.1 39 50.6
  Varies by provider (n = 20) 15 13.9 5 6.5
  Unknown (n = 5) 1 0.9 4 5.2
CRC screening champion(s) 0.19
  No (n = 39) 26 24.1 13 16.9
  Yes (n = 140) 77 71.3 63 81.8
  Unknown (n = 6) 5 4.6 1 1.3
CRC screening policy 0.01
  No (n = 13) 3 2.8 10 13.0
  Yes (n = 170) 104 96.3 66 85.7
  Unknown (n = 2) 1 0.9 1 1.3

CRCCP Colorectal Cancer Control Program, CHC Community Health Center, FQHC Federally Qualified Health Center, HS health system, FIT fecal immunochemical test, FOBT fecal occult blood test

aClinics with “unknown” or “missing” status were excluded in χ2 tests